Brief: Active Biotech Q3 Operating Loss Narrows To SEK 8.3 Mln
Nov 5 (Reuters) - Active Biotech AB (publ) ACTI.ST :
* ACTIVE BIOTECH INTERIM REPORT JANUARY – SEPTEMBER 2020
* Q3 OPERATING LOSS SEK 8.3 MILLION VERSUS LOSS SEK 9.3
MILLION
YEAR AGO
Source text for Eikon: ID:nGNXbdtkdc
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million